/
/
/

SMS Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2008Dec 2007Sep 2007Jun 2007Mar 2007
₹207 Cr₹238 Cr₹210 Cr₹242 Cr₹196 Cr₹248 Cr₹173 Cr₹197 Cr₹164 Cr₹246 Cr₹161 Cr₹167 Cr₹135 Cr₹149 Cr₹149 Cr₹159 Cr₹64 Cr₹61 Cr₹121 Cr₹175 Cr₹163 Cr₹171 Cr₹149 Cr₹130 Cr₹113 Cr₹96 Cr₹80 Cr₹118 Cr₹117 Cr₹104 Cr₹101 Cr₹135 Cr₹125 Cr₹57 Cr₹47 Cr₹55 Cr₹51 Cr₹53 Cr
₹2 Cr₹3 Cr₹4 Cr₹1 Cr₹59 L₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹81 L₹51 L₹1 Cr₹2 Cr₹61 L₹80 L₹43 L₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹86 L₹92 L₹81 L₹3 Cr₹79 L₹58 L₹65 L₹75 L₹59 L₹1 Cr₹36 L₹61 L₹47 L₹1 Cr₹3 Cr₹54 L
₹209 Cr₹241 Cr₹214 Cr₹244 Cr₹197 Cr₹250 Cr₹175 Cr₹198 Cr₹166 Cr₹247 Cr₹163 Cr₹167 Cr₹136 Cr₹151 Cr₹151 Cr₹160 Cr₹65 Cr₹61 Cr₹123 Cr₹176 Cr₹164 Cr₹173 Cr₹150 Cr₹131 Cr₹114 Cr₹100 Cr₹81 Cr₹118 Cr₹118 Cr₹104 Cr₹102 Cr₹136 Cr₹125 Cr₹58 Cr₹47 Cr₹57 Cr₹54 Cr₹53 Cr
₹176 Cr₹208 Cr₹177 Cr₹204 Cr₹166 Cr₹216 Cr₹149 Cr₹174 Cr₹139 Cr₹220 Cr₹140 Cr₹147 Cr₹117 Cr₹134 Cr₹138 Cr₹154 Cr₹73 Cr₹73 Cr₹102 Cr₹136 Cr₹127 Cr₹136 Cr₹120 Cr₹112 Cr₹97 Cr₹88 Cr₹66 Cr₹101 Cr₹99 Cr₹93 Cr₹80 Cr₹114 Cr₹106 Cr₹48 Cr₹42 Cr₹46 Cr₹41 Cr₹38 Cr
₹43 Cr₹42 Cr₹47 Cr₹50 Cr₹40 Cr₹42 Cr₹35 Cr₹33 Cr₹35 Cr₹35 Cr₹30 Cr₹29 Cr₹27 Cr₹24 Cr₹21 Cr₹14 Cr-₹80,000-₹4 Cr₹29 Cr₹48 Cr₹46 Cr₹42 Cr₹35 Cr₹25 Cr₹22 Cr₹18 Cr₹21 Cr₹23 Cr₹24 Cr₹16 Cr₹26 Cr₹27 Cr₹24 Cr₹11 Cr₹7 Cr₹12 Cr₹14 Cr₹16 Cr
₹6 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹27 Cr₹27 Cr₹31 Cr₹34 Cr₹24 Cr₹29 Cr₹22 Cr₹20 Cr₹22 Cr₹22 Cr₹17 Cr₹15 Cr₹13 Cr₹11 Cr₹7 Cr₹84 L-₹13 Cr-₹16 Cr₹16 Cr₹35 Cr₹33 Cr₹34 Cr₹27 Cr₹16 Cr₹14 Cr₹9 Cr₹12 Cr₹14 Cr₹15 Cr₹8 Cr₹19 Cr₹19 Cr₹16 Cr₹9 Cr₹4 Cr₹9 Cr₹11 Cr₹13 Cr
₹20 Cr₹21 Cr₹23 Cr₹25 Cr₹19 Cr₹20 Cr₹17 Cr₹14 Cr₹16 Cr₹16 Cr₹12 Cr₹12 Cr₹9 Cr₹8 Cr₹5 Cr₹73 L-₹10 Cr₹9 Cr₹10 Cr₹25 Cr₹23 Cr₹22 Cr₹18 Cr₹11 Cr₹9 Cr₹6 Cr₹8 Cr₹10 Cr₹9 Cr₹6 Cr₹12 Cr₹13 Cr₹10 Cr₹10 Cr₹3 Cr₹6 Cr₹7 Cr₹6 Cr

Share Price Live Stats

Open (₹)374.00
Volume (₹)1.35 L
High (₹)389.55
Upper Circuit448.95
Low (₹)373.00
Lower Circuit299.35
Prev Close374.15
52W High (₹)447.80
Price389.45
52W Low (₹)231.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)3504.93 Cr
Div. Yield (%)0.11
PE Ratio34.23
Debt to Equity0.50
Price to Book3.02
Book Value70.36
EPS (TTM)10.93
Face Value1.00
ROE (%)11.91

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
SMSPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1901.5-18.5 (-0.96%)
1900.10
1984.80
4,56,833Cr
9182.5-56.5 (-0.61%)
9087
9467
2,45,426Cr
4860-190 (-3.76%)
4857
5066
1,87,320Cr
1133.9-57.1 (-4.79%)
1125.10
1187
1,13,217Cr
1380.8-42.7 (-3.00%)
1376.70
1426.10
1,12,212Cr
1853.3-85.2 (-4.40%)
1811.70
1949
1,01,155Cr
2124.6-46.9 (-2.16%)
2118.10
2192
97,626Cr
2336.1-46.8 (-1.96%)
2335
2419.20
96,859Cr
1162.3-15.7 (-1.33%)
1154.40
1179.90
96,406Cr
1658.9+13.6 (0.83%)
1622.60
1717
93,614Cr
389.45+33.9 (9.53%)
350.55
389.55
3,505Cr

Key Highlights of SMS Pharmaceuticals Ltd’s P&L

In 2025-03-31, SMS Pharmaceuticals Ltd reported total revenue of ₹788.97Cr, compared with ₹713.72Cr in 2024-03-31, reflecting SMS Pharmaceuticals Ltd turnover.

Depreciation was ₹34.34Cr and finance costs were ₹18.54Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹92.34Cr in 2025-03-31 as compared to ₹66.11Cr in 2024-03-31.

Net Profit (PAT) was ₹69.14Cr in 2025-03-31 compared with ₹49.83Cr in 2024-03-31.

Earnings per share (EPS) were ₹7.80 in 2025-03-31, compared with ₹5.89 in 2024-03-31.